Patients (n) | 3073 | 1482 | |
Age (years; mean [SD]) | 61.1 [11.4] | 61.7* [10.6] | |
Women (%) | 2583 (84.1%) | 1270 (85.7%) | |
Disease duration (years; mean [SD]) | 13.5 [10.6] | 15.7* [10.7] | |
Disease activity score (mean [SD]) | | | |
DAS28-ESR | 4.31† [1.32] | 4.29† [1.22] | 4.24† [1.30] |
DAS28-CRP | 3.59 [1.25] | 3.61[1.20] | 3.51 [1.23] |
Disease activity characteristics (median [first; third quartile]) | | | |
Tender joint count (0–28) | 2 [0; 4] | 2 [1; 5] | 2 [1; 5] |
Swollen joint count (0–28) | 1 [0; 4] | 2 [0; 5] | 1 [0; 4] |
ESR (mm/h; normal <20) | 39 [21; 60] | 38 [20; 58] | 40 [22; 60] |
CRP (mg/dl; normal <0.4) | 0.78 [0.23;2.09] | 0.82 [0.27; 2.30] | 0.72 [0.22; 1.98] |
mHAQ score (range 0–3) | 0.50 [0.10; 1.10] | 0.50 [0.12; 1.00] | 0.60 [0.12; 1.25] |
Patient’s pain VAS (10 cm) | 3.7 [1.9; 5.5] | 3.4 [3.4; 5.4] | 3.8 [2.0; 5.8] |
Patient’s global VAS (10 cm) | 4.0 [2.0; 5.6] | 3.8 [2.0; 5.8] | 4.1 [2.1; 5.7] |
Doctor’s global VAS (10 cm) | 2.9 [1.6; 4.7] | 3.1 [2.0; 4.9] | 3.1 [1.9; 4.9] |